Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Radford

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Patient Safety|May 26, 2022
Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Nephrology (Carlton, Vic.)|March 27, 2024
Island medicine longitudinal cohort study: Rapid rise in chronic kidney disease in rural and remote communitiesMatthew D Jose, Laura Cuthbertson, James Burgess, et al.
Expert Review of Clinical Pharmacology|July 18, 2022
Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapyWoldesellassie M Bezabhe, Jan Radford, Barbara C Wimmer, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|August 15, 2020
Engaging "hard-to-reach" men in health promotion using the OPHELIA principles: Participants' perspectivesLeigh Kinsman, Jan Radford, Shandell Elmer, et al.
Australian Journal of General Practice|May 28, 2019
Association of continuity of care with blood pressure control in patients with chronic kidney disease and hypertensionMasuma Khanam, Alex Kitsos, Jim Stankovich, et al.
Expert Review of Clinical Pharmacology|April 22, 2022
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulantsWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Frontiers in Pharmacology|April 19, 2021
Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
European Journal of Clinical Investigation|November 22, 2020
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Family Medicine and Community Health|February 27, 2026
Time to care: the lived experience of receiving care from a primary care service for people with frequent hospital admissionsDeirdre McGowan, Tania Winzenberg, Emily Hansen, et al.
JMIR Research Protocols|September 17, 2020
Chronic Kidney Disease in Tasmania: Protocol for a Data Linkage StudyTimothy Saunder, Alex Kitsos, Jan Radford, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Patient Safety|May 26, 2022
Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Nephrology (Carlton, Vic.)|March 27, 2024
Island medicine longitudinal cohort study: Rapid rise in chronic kidney disease in rural and remote communitiesMatthew D Jose, Laura Cuthbertson, James Burgess, et al.
Expert Review of Clinical Pharmacology|July 18, 2022
Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapyWoldesellassie M Bezabhe, Jan Radford, Barbara C Wimmer, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|August 15, 2020
Engaging "hard-to-reach" men in health promotion using the OPHELIA principles: Participants' perspectivesLeigh Kinsman, Jan Radford, Shandell Elmer, et al.
Australian Journal of General Practice|May 28, 2019
Association of continuity of care with blood pressure control in patients with chronic kidney disease and hypertensionMasuma Khanam, Alex Kitsos, Jim Stankovich, et al.
Expert Review of Clinical Pharmacology|April 22, 2022
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulantsWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Frontiers in Pharmacology|April 19, 2021
Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
European Journal of Clinical Investigation|November 22, 2020
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Family Medicine and Community Health|February 27, 2026
Time to care: the lived experience of receiving care from a primary care service for people with frequent hospital admissionsDeirdre McGowan, Tania Winzenberg, Emily Hansen, et al.
JMIR Research Protocols|September 17, 2020
Chronic Kidney Disease in Tasmania: Protocol for a Data Linkage StudyTimothy Saunder, Alex Kitsos, Jan Radford, et al.
Pageof 6